Hatchery evaluation of erythromycin phosphate injections in prespawning spring chinook salmon

North American Journal of Aquaculture

Volumn 64, Issue 3, 2002, Pages 167-174

  Haukenes, Alf H ^a   Moffitt, Christine M ^a  

^a UNIVERSITY OF IDAHO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCORHYNCHUS TSHAWYTSCHA; RENIBACTERIUM SALMONINARUM; VERTEBRATA;

EID: 0036074248     PISSN: 15222055     EISSN: 15488454     Source Type: Journal    
DOI: 10.1577/1548-8454(2002)064<0167:HEOEPI>2.0.CO;2     Document Type: Article

References (37)

1. Agresti, A. 1990. Categorical data analysis. Wiley, New York.
2. Amacher, D. E., S. J. Schomaker, and J. A. Retsema. 1991. Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. Antibacterial Agents and Chemotherapy 35:1186-1190.
3. Armstrong, R. D., T. P. T. Evelyn, S. W. Martin, W. Dorward, and H. W. Ferguson. 1989. Erythromycin levels within eggs and alevins derived from spawning broodstock chinook salmon Oncorhynchus tshawytscha injected with the drug. Diseases of Aquatic Organisms 6:33-36.
4. Bandin, I., Y. Santos, A. E. Toranzo, and J. L. Baria. 1991. MIC’s and MBC’s of chemotherapeutic agents against Renibacterium salmoninarum. Antimicrobial Agents and Chemotherapy 35:1011-1013.
5. Brown, L. L., L. J. Albright, and T. P. T. Evelyn. 1990. Control of vertical transmission of Renibacterium salmoninarum by injection of antibiotics into maturing female coho salmon Oncorhynchus kisutch. Diseases of Aquatic Organisms 9:127-131.
6. Bullock, G. L., and S. L. Leek. 1986. Use of erythromycin in reducing vertical transmission of bacterial kidney disease. Veterinary and Human Toxicology 28(Supplement 1):18-20.
7. Cantor, A. B. 1997. Extending SAS survival analysis techniques for medical research. SAS Institute, Cary, North Carolina.
8. Evelyn, T. P. T., J. E. Ketcheson, and L. Prosperi-Porta. 1986. Use of erythromycin as a means of preventing vertical transmission of Renibacterium salmonina-rum. Diseases of Aquatic Organisms 2:7-11.
9. Evenden, A. J., T. H. Grayson, M. L. Gilpin, and C. B. Munn. 1993. Renibacterium salmoninarum and bacterial kidney disease-Annual Review of Fish Diseases 1993:87-104.
10. Flood, L. P, M. J. Carvan III, L. Jaeger, D. L. Busbey, D. M. Gatlin III, and W. H. Neill. 1996. Reduction in hepatic microsomal P-450 and related catalytic activity in farm raised red drum. Journal of Aquatic Animal Health 8:13-21.
11. Goksoyr, A., and H. E. Larsen. 1991. The cytochrome p450 system of Atlantic salmon (Salmo salar): I. Basal properties and induction of p450 1A1 in liver of immature and mature fish. Fish Physiology and Biochemistry 9:339-349.
12. Greenlees, K. J. 1997. Laboratory studies for the approval of aquaculture drugs. Progressive Fish-Culturist 59:141-148.
13. Groman, D. B., and G. W. Klontz. 1983. Chemotherapy and prophylaxis of bacterial kidney disease with erythromycin. Journal of the World Mariculture Society 14:226-235.
14. Haukenes, A. H., and C. M. Moffitt. 1999. Concentrations of erythromycin in maturing salmon following intraperitoneal injection of one of two drug formulations. Journal of Aquatic Animal Health 11: 61-67.
15. Hayton, W. L. 1999. Considerations in compartmental pharmacokinetic modeling in fish. Pages 55-72 in D. J. Smith, W. H. Gingerich, and M. G. Beconi-Barker, editors. Xenobiotics in fish. Kluwer Aca-demic/Plenum Publishers, New York.
16. Kiryu, Y., and C. M. Moffitt. 2001. Acute LD50 and kidney histopathology following injection of ery-thomycin (Erythro-200) and its carrier in spring chinook salmon. Journal of Fish Diseases 24:409-416.
17. Kiryu, Y. K., and C. M. Moffitt. In press. Models of comparative toxicity of injectable erythromycin in four salmonid species. Aquaculture.
18. Klontz, G. W. 1983. Bacterial kidney disease in sal-monids: an overview. Pages 177-200 in D. P. Anderson, M. Dorson, and P. H. Dubourget, editors. International symposium on the antigens of fish pathogens: development and productions for vaccines and serodiagnostics. Collection Fondation, Marcel Merieux, Lyon, France.
19. Larrey, D., C. Funck-Brentano, P Breil, J. Vitaux, C. Theodore, G. Babany, and D. Pessayre. 1983. Effects of erythromycin on hepatic drug metabolizing enzymes in humans. Biochemical Pharmacology 32: 1063-1068.
20. Larsen, H. E., M. Celander, and A. Goksoyr 1992. The cytochrome P450 system of Atlantic salmon (Salmo salar): II. Variations in the hepatic catalytic activities and isozyme patterns during the annual reproductive cycle. Fish Physiology and Biochemistry 10:291-301.
21. Lee, E. G. H., and T P T Evelyn. 1994. Prevention of vertical transmission of the bacterial kidney disease agent Renibacterium salmoninarum by broodstock injection with erythromycin. Diseases of Aquatic Organisms 18:1-4.
22. Lee, E. T. 1992. Statistical methods for survival analysis, 2nd edition. Wiley, New York.
23. Meyers, T T, S. Short, C. Farrington, K. Lipson, H. J. Geiger, and R. Gates. 1993a. Comparison of the enzyme-linked immunosorbent assay (ELISA) and the fluorescent antibody test (FAT) for measuring the prevalences and levels of Renibacterium sal-moninarum in wild and hatchery stocks of salmonid fishes in Alaska, USA. Diseases of Aquatic Organisms 16:181-189.
24. Meyers, T. T, S. Short, C. Farrington, K. Lipson, H. J. Geiger, and R. Gates. 1993b. Establishment of a negative-positive threshold optical density value for the enzyme-linked immunosorbent assay (ELISA) to detect soluble antigen of Renibacterium salmon- inarum in Alaskan Pacific salmon. Diseases of Aquatic Organisms 16:191-197.
25. Meyers, T. R., F. Thrower, S. Short, K. Lipson, J. Joyce, C. Farrington, and S. Doherty. 1999. Different prevalences of Renibacterium salmoninarum detected by ELISA in Alaskan chinook salmon On-corhynchus tshawytscha spawned from freshwater and seawater. Diseases of Aquatic Organisms 35: 101-105.
26. Moffitt, C. M. 1991. Oral and injectable applications of erythromycin in salmonid fish culture. Veterinary and Human Toxicology 33:49-53.
27. Moffitt, C. M., and A. H. Haukenes. 1995. Regional investigational new animal drug permits for erythromycin as a feed additive and injectable drug. Progressive Fish-Culturist 57:97-101.
28. Moffitt, C. M., and Y. Kiryu. 1999. Toxicity, terato-genesis, and efficacy of injectable erythromycin (Erythro-200) administered repeatedly to adult spring chinook salmon. Journal of Aquatic Animal Health 11:1-9.
29. Moffitt, C. M., and Y. Kiryu. 2001. Acute and chronic toxicity following parenteral application of erythromycin to maturing spring chinook salmon held at two water temperatures. Journal of Aquatic Animal Health 13:8-19.
30. Moffitt, C. M., and J. A. Schreck. 1988. Accumulation and depletion of orally administered erythromycin thiocyanate in tissues of chinook salmon. Transactions ofthe American Fisheries Society 117:394-400.
31. Pascho, R. J., D. G. Elliott, and J. M. Streufert. 1991. Broodstock segregation of spring chinook salmon Oncorhynchus tshawytscha by use of enzyme-linked immunosorbent assay (ELISA) and fluorescent antibody technique (FAT) affects prevalence and levels of Renibacterium salmoninarum infection in progeny. Diseases of Aquatic Organisms 12:25-40.
32. Pascho, R. J., T D. Goodrich, and C. L. McKibben. 1997. Evaluation by enzyme-linked immunosorbent assay (ELISA) of Renibacterium salmoninarum bacterins affected by persistence of bacterial antigens. Journal of Aquatic Animal Health 9:99-107.
33. SAS Institute. 1995. SAS/STAT software: changes and enhancements through release 6.11. SAS Institute, Cary, North Carolina.
34. Stoffregen, D. A., P R. Bowser, and J. G. Babish. 1996. Antibacterial chemotherapeutants for finfish aquaculture: a synopsis of laboratory and field efficacy and safety studies. Journal of Aquatic Animal Health 8:181-207.
35. Williams, D. E., B. S. Masters, J. J. Lech, and D. R. Buhler. 1986. Sex differences in cytochrome P-450 isozyme composition and activity in kidney micro-somes of mature rainbow trout. Biochemical Pharmacology 35:2017-2023.
36. Wolf, K., and C. E. Dunbar. 1959. Test of 34 therapeutic agents for control of bacterial kidney disease in trout. Transactions of the American Fisheries Society 88:117-124.
37. Wrighton, S. A., P Maurel, E. Schuetz, P Watkins, B. Young, and P Guzelian. 1985. Identification ofthe cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450. Biochemistry 24:2171-2178.